{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By DAVID GELLES", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "GELLES"}]}, "abstract": "Valeant Pharmaceuticals International says it will pay $11 billion, or $173 a share, for Salix Pharmaceuticaals, up from $158 a share; Endo International withdraws its $11.2 billion bid to buy Salix.", "type_of_material": "News", "word_count": "668", "lead_paragraph": "The bidding-war triumph is a much-needed win for Valeant after it failed last year in its pursuit of Allergan, the maker of Botox.", "pub_date": "2015-03-17T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Raising Its Bid, Valeant Cinches a Deal ", "print_headline": "Raising Its Bid, Valeant Cinches a Deal"}, "snippet": "The bidding-war triumph is a much-needed win for Valeant after it failed last year in its pursuit of Allergan, the maker of Botox.", "multimedia": [{"height": 126, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 424, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "424", "xlarge": "images/2015/03/17/business/db-drug-web1/db-drug-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/03/17/business/dealbook/valeant-raises-offer-for-salix.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Salix Pharmaceuticals Ltd", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Endo International PLC", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "5506cab438f0d85e90e00274", "source": "The New York Times"}